Wolters Kluwer Launches AI-enhanced UpToDate Enterprise Edition in EMEA
4.6.2025 16:30:00 EEST | Business Wire | Press release
Wolters Kluwer Health today announced its UpToDate® Enterprise Edition will be available to healthcare systems and hospitals in the Europe, Middle East, and Africa (EMEA) region beginning in Q3. Designed specifically for large healthcare systems and hospitals, the clinical decision support (CDS) solution, which features AI enhancements, is designed to support healthcare administrators and clinicians to help deliver consistently high-quality care. Wolters Kluwer Health will demonstrate the solution at HIMSS25 Europe in Paris, June 10-12, 2025.
“Leveraging AI technology, UpToDate Enterprise Edition goes beyond traditional decision support to provide unparalleled quality that supports streamlined, integrated workflows and faster time-to-answers, ultimately fostering patient engagement and transforming care delivery,” said Christian Cella, Vice President, International Segment for Clinical Effectiveness at Wolters Kluwer Health. “With UpToDate Enterprise becoming available in EMEA, we are extending Wolters Kluwer’s commitment to enhancing clinical decision-making worldwide.”
For decades, healthcare professionals around the world have trusted UpToDate clinical decision support to enable confident decision-making and reduce variability in care. The UpToDate Enterprise Edition solution builds on that value to include advanced features, insights, and technology innovations to help them meet these current and emerging industry challenges. The solution is in early release at 40 of the largest health systems in EMEA joining the over 350 health systems in North America using the UpToDate Enterprise Edition.
“UpToDate has been an extremely valuable clinical decision support resource for Icelandic health institutions. UpToDate Enterprise Edition adds new features including AI that will aid our staff to make smarter clinical decisions to further help improve patient care,” says Runólfur Pálsson, CEO of Landspítali University Hospital and Professor of Medicine at the Faculty of Medicine of the University of Iceland.
UpToDate Enterprise Edition offers harmonized content and solutions for the entire care team, empowering them to make more informed, confident, and impactful decisions. With its AI-Enhanced Search capabilities, clinicians can now experience the efficiency of receiving highly focused verbatim answers from a market leading clinical decision solution using natural language queries—a time-saver for busy healthcare professionals. The AI-powered Analytics Dashboard offers healthcare organizations the ability to harness valuable organizational data for improved efficiency and educational opportunities.
“Deploying UpToDate Enterprise Edition is an important initiative in supporting our digital innovation strategy,” said Professor Adrian Harris, Chief Medical Officer at the Royal Devon University Healthcare NHS Foundation Trust. “By leveraging the data, analytics and AI capabilities now available within UpToDate, we can further support medical education and optimize clinical decision making, helping us deliver the best possible care for all patients and enabling our local population to stay well.”
This enhanced solution unifies care teams and administrators with a focus on workflow innovation, analytics, and advanced care features. With access across teams, organizations can:
- Manage complexity by advancing clinical decisions
- Enhance satisfaction and collaboration by aligning all members of the care team to the same trusted UpToDate content with advanced decision-making features
- Help alleviate burnout through improved workflow capabilities
- Improve resource utilization and business outcomes via system-wide data and insights and self-service analytics, such as system-wide topic usage, UpToDate topic benchmarking, and CME accreditation activity.
In the Frost Radar™: Clinical Decision Support System, 2025report, Wolters Kluwer was the only one named both a “Company to Action” and the market leader for innovation. Frost & Sullivan screened and analyzed more than 60 clinical decision support vendors across point-of-care segments and short-listed 10 companies based on a detailed analysis of their corporate growth potential and ability to drive visionary innovation in this space.
Learn more about UpToDate Enterprise Edition in EMEA.
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.
Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250604785080/en/
Contacts
Media Contact
Suzanne Moran
Associate Director, External Communications
Health
Wolters Kluwer
Office/Mobile: +1 6178938586
Suzanne.Moran@Wolterskluwer.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Suzano Reports 36% Increase in Third Quarter Net Revenue Following Consolidation of Arbex6.11.2026 01:23:00 EET | Press release
Suzano (B3: SUZB3 / NYSE: SUZ) , the world’s largest pulp producer, announces its results for the third quarter of 2026 (3Q26), which for the first time include Arbex, the joint venture between Suzano and Kimberly-Clark established in July this year. Driven primarily by the consolidation of Arbex’s contribution, Suzano reported net revenue of BRL16.5 billion, an increase of 36% on the same period last year and a new quarterly record in the company’s 102-year history. Adjusted EBITDA totaled R$5.7 billion in 3Q26, up 9% on the same basis of comparison. Operating cash generation reached R$3.8 billion, an increase of 12%. Net income totaled R$2.1 billion. As announced following the completion of the transaction with Kimberly-Clark, Suzano holds a 51% equity interest in Arbex and will therefore fully consolidate the joint venture’s financial statements from this quarter onwards.1 “This quarter marks the beginning of a new phase for Suzano. With Arbex, we are now a broader business, both ge
iQmetrix Unveils Built-In Intelligence for Every Role in Telecom Commerce at Its 2026 Telecom Industry Address5.11.2026 23:39:00 EET | Press release
iQmetrix, the global provider of Intelligent Commerce Operating Systems for telecom, last week shared highlights from its 2026 Telecom Industry Address and Product Announcements, held virtually on Oct. 28 in two sessions, one for North American audiences and one for European audiences. The address was built around one theme: intelligence. Telecom commerce is moving from systems that record the business to systems that act on it, and the announcements put that intelligence in the hands of every role, from the sales associate at the counter, to the finance manager in the back office, to the corporate view leading the channel experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105003162/en/ "Right now telecom providers are competing in a race to the bottom on price that no one wins. The way out is intelligence. Not AI bolted onto a fragmented tech stack, but intelligence built into how commerce runs. Information plus
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.11.2026 23:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to nine newly hired non-executive employees. The equity awards were granted on November 2, 2026, and consisted of options to purchase an aggregate of 59,275 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 28,200 shares. These options have an exercise price per share equal to $8.41, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted s
Graco QUANTM i230 Brings Electrification to High-Flow Fluid-Transfer Applications5.11.2026 23:16:00 EET | Press release
Graco Inc. is helping manufacturers electrify high-flow fluid-transfer applications with the global launch of the 3-inch QUANTM® i230, bringing efficient electric drive technology to demanding processes that have traditionally relied on pneumatic pumps. Paint, coatings and ceramics manufacturers depend on diaphragm pumps for their flexibility, reliability and ability to handle challenging materials. But pneumatic pumps also depend on compressed air — an energy-intensive plant resource whose available capacity can fluctuate as demand changes across a facility. The QUANTM i230 gives manufacturers another option for qualified high-flow applications. By combining familiar diaphragm pump capabilities with electric operation, the pump helps manufacturers move more material, reduce transfer bottlenecks and lower energy consumption by up to 80% compared to pneumatic pumps, while maintaining operating flexibility. “High-flow processes in industries like paint, coatings and ceramics have continu
ThetaRay Named World’s Best Software Provider for AML and Sanctions Screening in the 2026 Euromoney Transaction Banking Awards5.11.2026 20:30:00 EET | Press release
ThetaRay, a global leader in AI-native financial crime compliance infrastructure, has been named The World’s Best Software Provider for AML and Sanctions Screening at the 2026 Euromoney Transaction Banking Awards. Evaluated by Euromoney’s editorial and research team, ThetaRay was recognized for technology excellence, verifiable performance, and advancing the modern transaction banking value chain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105714764/en/ The recognition reinforces ThetaRay’s standing as foundational compliance infrastructure for global institutions, closely following Chartis Research ranking ThetaRay #8 globally in the Financial Crime and Compliance50 (FCC50) 2026 report and naming the company a Category Winner for Explainable AI. “Our customers operate on the front lines against illicit networks exploiting the speed and scale of modern payment rails, which means defensive technology must meet and outp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom